European Leukemia Trial Registry
Trial: ALL GMALL Nelarabine

More Details
Title Nelarabine in T-ALL
Scientific Title Multicentric therapy optimization study for T-lymphoblastic lymphoma in adult patients and adolescents >=18 years
Short Title ALL GMALL Nelarabine
Trialgroup GMALL
Type of Trial multicentric
Disease Acute lymphoblastic leukemia(ALL) T-LBL
Age >= 18 years
Status Closed
Start of Recruitment 01.04.2004
Leader Hoelzer, Prof. Dr. med., Dieter
Contactperson

Study Physician
Gökbuget, Dr. med., Nicola
Tel: +49 (0)69 6301-6366
Fax: +49 (0)69 6301- 7463
Email: goekbuget@em.uni-frankfurt.de

Study Centre
Kotthoff, Roswitha
Tel: +49 (0)69 6301 87146
Fax: +49 (0)69 6301 7463
Email: r.kotthoff@em.uni-frankfurt.de

Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
Remark Amendment 7 from 28.02.2008
created 06.07.2006 Anja Hellenbrecht
changed 13.11.2014 Alexandra Lucaciu
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org